Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Short version: I’m fine. Longer version: I just saw my oncologist, and he’s pretty satisfied with everything. My M-protein level—the primary measure of cancerous plasma cells in my bone marrow—has been sneaking upward for the past few months, but in October it plateaued at the same level as September. Here’s a special expanded version of my usual M-protein chart:

I started out at 4.38 when I was first diagnosed with multiple myeloma, and the initial chemotherapy got that down to about 1.0. The maintenance meds got it down to 0.3, but after we halted the evil dex1 it drifted up to 0.58. Higher is worse, but as you can tell from the chart, the entire past year has been fairly stable, and the minor ups and downs don’t mean a lot. An M-protein level of 0.58 grams is roughly equivalent to a cancer load of about 3-4 percent, and my body can tolerate that basically forever. Eventually my M-protein level will rise above 1.0 or so, and then it will be time to switch to a second-line med.

However, my oncologist’s satisfaction was mostly based on other stuff that I don’t usually write about. There are three types of plasma cells: G, A, and M.2 My cancer happens to be of the G cells. However, my A-type cells have increased quite a bit over the past few months, and apparently that’s an indication that my immune system is returning to normal. So that’s good. Also, my Kappa light chains are pretty low, and my Kappa/Lambda ratio is nice and stable.3 That’s also good. Put it all together and I’m in pretty stable shape.

However, the med I’m taking now can produce rashes in some people. It turns out I’m one of them. In my case, they’re little red dots that showed up on my lower legs last week, then spread to my upper legs, and are now invading my stomach. How far will they go? Beats me. But if they go much further, they’ll invade my face and I’ll look like I have a permanent case of the measles. Oh well.

1That’s dexamethasone, a corticosteroid that helps fight multiple myeloma. However, it has bad long-term side effects, so it can only be used for a few months at a time.

2This is not precisely the right terminology, but it’s close enough.

3For the record, I have IgG Kappa light chain multiple myeloma.

GREAT JOURNALISM, SLOW FUNDRAISING

Our team has been on fire lately—publishing sweeping, one-of-a-kind investigations, ambitious, groundbreaking projects, and even releasing “the holy shit documentary of the year.” And that’s on top of protecting free and fair elections and standing up to bullies and BS when others in the media don’t.

Yet, we just came up pretty short on our first big fundraising campaign since Mother Jones and the Center for Investigative Reporting joined forces.

So, two things:

1) If you value the journalism we do but haven’t pitched in over the last few months, please consider doing so now—we urgently need a lot of help to make up for lost ground.

2) If you’re not ready to donate but you’re interested enough in our work to be reading this, please consider signing up for our free Mother Jones Daily newsletter to get to know us and our reporting better. Maybe once you do, you’ll see it’s something worth supporting.

payment methods

GREAT JOURNALISM, SLOW FUNDRAISING

Our team has been on fire lately—publishing sweeping, one-of-a-kind investigations, ambitious, groundbreaking projects, and even releasing “the holy shit documentary of the year.” And that’s on top of protecting free and fair elections and standing up to bullies and BS when others in the media don’t.

Yet, we just came up pretty short on our first big fundraising campaign since Mother Jones and the Center for Investigative Reporting joined forces.

So, two things:

1) If you value the journalism we do but haven’t pitched in over the last few months, please consider doing so now—we urgently need a lot of help to make up for lost ground.

2) If you’re not ready to donate but you’re interested enough in our work to be reading this, please consider signing up for our free Mother Jones Daily newsletter to get to know us and our reporting better. Maybe once you do, you’ll see it’s something worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate